Introduction
Malignant tumors of the lacrimal sac are unusual and most of them are epithelial tumors. Primary non-Hodgkin lymphomas (NHL) of this area are extremely rare [1] [2] [3] . These patients have symptoms like epiphora and swelling in periorbital region. Early suspicion and immediate biopsy are prerequisites for the diagnosis of malignancies in this area.
We present a patient with primary B cell NHL of the lacrimal sac developed secondary to chronic dacryocystitis and reviewed literature.To our knowledge it is the first case that primary lymphoma of the lacrimal sac was developed secondary to chronic dacryocystitis
Material and Methods
Forty-four years old female patient with complaints of epiphora on the right eye for eight years and a growing mass in the right periorbital region for six months referred to our clinic with preliminary diagnosis of chronic dacryocystitis.
Physical examination revealed a firm, non-tender and irregular mass extending from medial canthus through nasolabial sulcus and lateral nasal cavity (Picture 1).
Endoscopic nasal examination revealed hyperemic mucosa with edema at the level of lacrimal sac.
In the ophthalmologic examination, there was no drainage through right nasolacrimal system by irrigation, and eye movements were within normal limits.
Anterior segment, optical disc, macula and visual examination were found within normal limits in both eyes.
Picture 1: Physical examination (right eye and solid mass involving the lacrimal sac region

Abstract
Objective: Primary non-Hodgkin lymphoma of the lacrimal sac is an extremely rare tumor. In this article, we report a 44-year-old female who was referred for dacryocystorhinostomy with complaints of epiphora and swelling on the right lacrimal sac region. She had slight epiphora for 8 years, which increased within 6 months, with concomitant swelling between the eye and the nose. A hard and fixed mass was detected on palpation just below the medial canthus. Magnetic resonance imaging showed a 30x35 mm tumoral, lesion which invaded the medial wall of the right orbit and compressed the medial rectus muscle. Histopathologic examination of the tumor revealed a small B cell non-Hodgkin lymphoma. As a conclusion, we suggest that if symptoms of a chronic dacryocystitis patient deteriorates, malignancy should be suspected Magnetic resonance imaging scans showed a mass of 30 x 35 mm in size, invading the nasal side of the right orbita, including the right nasolacrimal duct and continuing to the level of inferior nasal concha. Compression of the medial rectus muscle was observed. Other structures were normal in right orbita (Picture 2).
Picture 3A Hematoxylin-eosin staining, monotonous, round-to-oval nuclei, indistinguishable from the cytoplasm tumor cells (second) (H&E, X400)
Multiple incisional biopsies were made from the mass and sent to pathology department. Histopathological examination of the specimens revealed a mixture of small to medium sized, mildly atypical uniform lymphocytes ( Figure 3A , B).
Picture 3B
Diffuse membranous staining lymphocytes with CD20, X100 (CD20;Immunohistochemistry for the B-cell Marker.) Immunohistochemically, tumor cells were negative for TTF1, NSE, synaptophysin, chromogranin and positive for leukocyte common antigen. The lymphoid cells were strongly and diffuse positive for CD79a, CD20, bcl-2 and negative for CD3, CD45Ro ( Figure  3B ). Histopathologic and immunohistochemical findings revealed a small B cell non-Hodgkin lymphoma.
Afterwards, whole body scans were performed and the patient was found free of any metastasis. The patient was treated with CHOP regimen chemotherapy (CT) for 8 cycles. Two months after the end of chemotherapy, only moderate epiphora was observed during physical examinations.
Discussion
Lymphoma arising in the lacrimal sac is extremely rare. In literature, nearly 50 cases of primary lacrimal sac lymphoma have been described over a period of 30 years. Primary neoplasms originating from lacrimal sac are epithelial (75%) or non-epithelial (25%) tumors, such as mesenchymal tumors (12%), melanoma (5%), and malignant lymphomas (6%). [1] [2] [3] [4] Carlin and Henderson [1] reported the median age at onset to be 51 years for lacrimal sac lymphoma. Primary nasolacrimal duct lymphoma is more common in females [3, 4] . Predominant symptoms of lacrimal sac lymphoma are epiphora and swelling like acute attack of chronic dacryocystitis [1] [2] [3] . Blood in the tears has been reported only once. Our case was a forty-four year old female patient with complaints of epiphora on the Eye Study (6) . However, a insignificant increased risk of cortical cataract (5) and posterior subcapsular cataract (6) were also reported in these studies respectively in a similar way to our results. Our study differs from these trials with our cataract assessment technique and in our opinion this is one of the strengths of our study. Having not been using data from medical records, we may have reduced the risk of '' misclassification bias''. Sure, encountering with some artefacts in the LD analysis process is possible but we have tried to avoid from these artefacts by using a standardization method in the measurement procedure.
Nonetheless, some factors such as back scattering of light from the anterior lens area, shadows and light attrition may decrease the amount of light transmitted to the posterior pole of the lens and this may have caused nuclear and posterior area to appear less dense (26). Another limitation of the current study is that it is a not prospective cohort study. We have performed two-way ANOVA, ANCOVA and multiple regression analysis in order to evaluate the effect of gender and age on LD. Although statin use was still found to be more effective on LD than age and gender, our results may have been influenced by some other unpredictable factors. We have excluded the patients with any refractive errors within ± 3 diopters spherical equivalent and any systemic diseases such as diabetes mellitus, hypertension and connective-tissue diseases. Nevertheless, we know that anti-hyperlipidemic treatment is used for cardiovascular disorders and the patients usually have comorbidities. Surely, some factors like these may have affected our resultsright eye for eight years and a growing mass in the right periorbital region for six months, and pathological diagnosis of the tumor was lymphoma. This case is consistent with literature as the age and complaints of the patient, and also pathological diagnosis being more frequently seen in female patients.
Primary lymphoma of the lacrimal sac is usually Bcell origin. Majority of B cell lymphomas are diffuse large B cell lymphomas (DLBCL) that runs an aggressive course but potentially curable [6] . The other common group is mucosa associated lymphoid tissue (MALT) type lymphomas. Only 1 case of natural killer T-cell lymphoma (NK/T-cell type) was presented before. Its prognosis is worse than the others [7] . Our case was small B cell lymphoma but biopsy specimen size was not enough for subtyping.
The treatment modalities consist of surgery, radiotherapy (RT), CT or a combination of both. RT and/or CT are considered as the primary and definitive treatment [3] [4] [5] . Extensive surgery is avoided for functional and cosmetic preservation of the eye [6, 7] .
In order to obtain a biopsy we used transnasal endoscopic approach to prevent skin spread of the tumor and cosmetic deformity. After the histopathological diagnosis of NHL, the patient was given a CHOP regimen of 8 cycles similar to current approach.
Most common pathology of previous ten years cases was DLBCL (60%). One of them were small B-cell lymphoma like our case and one of them was MALT lymphoma. Chai [15] performed surgery alone as a treatment. The other authors preferred CT, mostly CHOP protocol. Two patients treated with CT protocols died also because of systemic factors. Except these two patients no evidence of recurrent tumors has been seen for any other patients with a mean follow-up of 17 months and these treatments have controlled the disease successfully without medical complications. Generally there was no significant difference in survival rates between RT and CT and five year overall survival rate of patients were 80 % [9 -17] (Table 1) .
The major adverse factors that affect the prognosis of primary lymphoma of nasolacrimal duct seem to be clinical stage and histological type [6] [7] [8] . Our patient was treated with CT and at 24 months follow-up she was alive and free of the disease. There was only one case of small B-cell lymphoma of nasolacrimal duct was reported before and that case died of other causes (pulmonary thromboembolism). So for this histological subtype there is not enough data on survival in comparison to our case.
Conclusion
Lymphoma of the lacrimal sac is an extremely rare tumor. Suspicion and immediate biopsy are prerequisites for the early diagnosis of malignancies in this area.
Otorhinolaryngologists and ophthalmologists must be aware of lacrimal sac tumors in patients with epiphora and rapid swelling.
